Ingeteam is calling on the European administrations to speed up the procedures for installing renewables. “The technology is ready to multiply capacity and reduce energy dependence,” said Adolfo Rebollo, CEO of the Basque group.
The bloody war between Russia and Ukraine will have a positive consequence – perhaps the only one – for the energy policies of European countries: it will accelerate investment in renewable energies to reduce dependence, especially on Russian gas.
To move towards this goal, “we need to develop a lot of wind, solar and hydro in Europe,” said Adolfo Rebollo, CEO of Ingeteam.
“We have been betting on renewable energies and their development for 50 years and they have not paid any attention to us. The technology is ready, we just need to speed up the procedures and permits for their installation,” said the Basque group’s executive to the different administrations.
Read more on the subject and find the most important business headlines of the day with the Born2Invest mobile app.
Complying with the climate pact
In this line, Rebollo explained that with green hydrogen there is a great opportunity for renewables. “The replacement of the grey hydrogen consumed in the world by green hydrogen alone will double the capacity of renewables”. “In addition,” continued the CEO of the Basque group, “in order to comply with European strategies and the climate change pact, the current capacity must be multiplied by 10.
Ingeteam’s 2024 strategic plan foresees a 44% increase in turnover and a $1.1 billion (€1 billion) increase.
To face this renewable boom, Ingeteam has prepared a 2022-2024 strategic plan that sets itself the target of increasing its turnover by 44%, reaching a business of close to $1.1 billion (€1 billion) and a minimum target of 5% profitability in profit before tax.
The company chaired by Teresa Madariaga will also hire 1,000 people over the three-year period. It currently has a workforce of 4,100 employees.
Investments of $230 million (€210 million) in renewables
As for the investments foreseen, Ingeteam will allocate a total of $230 million (€210 million), $153 million (€140 million) will be used in R&D activities, and $76.7 million (€70 million) in new facilities and improvements to production plants.
With the 2024 plan, the group specializing in power electronics and control, among others, seeks to grow in renewables, but also in transport and efficient consumption of electricity.
Despite the current armed conflict, Ingeteam has an order book of more than $877 million (€800 million) and rules out a negative impact on its sales due to its business in Russia, “which is 1%”, said Adolfo Rebollo.
The Basque group, which exports 80% of its production, has an order book of more than $877 million (€800 million)
Ingeteam, which is celebrating its 50th anniversary, has reorganized itself into seven sectors and three global segments in its commitment to electrification. It has an internationalized structure, present in 24 countries on five continents, and exports 80% of its production.
The company closed the 2019-2021 strategic plan at 97% of the target, $740 million (€675 million) in business, and with ‘sustained’ profitability – a profit of around $14. million (€13 million) – but weighed down by the effects of the pandemic, the cost of energy, insurance, raw materials, and global logistics.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in elEconomista.es, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Malta Approves Three New Cannabis Clubs and Holds First Harm Reduction Training Sessions
According to Malta's rules on cannabis clubs, only the societies listed on the ARUC website can grow and distribute cannabis...
Of the 346 Fintech Companies in Colombia, 35.6% Focus on the Digital Credit Market
Most of the fintech companies in Colombia, 35.6% of the total, are dedicated to granting digital loans. There are also...
LUNC Capitalization Exceeds $1 billion – How High Will the Price Go?
Terra was designed to power an ecosystem of stablecoins, with the goal of creating more accessible and efficient blockchain applications....
Aspen Pharmacare Buys Sandoz’s Business in China for Over €90 Million
With a history of 170 years, Aspen is a multinational pharmaceutical company with a presence in both emerging and developed...
Vortex Fights Food Waste in Italy
Throwing away food causes a loss of over 22.8 billion euros. Vortex, a company that gives a second life to...
Africa2 weeks ago
Bank of Africa Registered Sustained Growth in the Third Quarter
Crypto7 days ago
Bitcoin Soars 130% This Year: Will It Reach New All-Time Highs in 2024?
Biotech1 week ago
SeniorDomo Continues Commitment Abroad and Starts Operations in France
Biotech3 days ago
Roche Will Pay Up to €2.8 Billion for Carmot Therapeutics